Prevalence and susceptibility pattern of methicillin-resistant Staphylococcus aureus isolates among healthy women in Zaria, Nigeria

African Journal of Biotechnology

Volumn 4, Issue 11, 2005, Pages 1321-1324

  Onanuga, Adebola ^a   Oyi, Avosuahi R ^a   Onaolapo, Josiah A ^a  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

Healthy women; Methicillin resistant Staphylococcus aureus; Prevalence; Susceptibility

Indexed keywords

AMPICILLIN; CEFALEXIN; CIPROFLOXACIN; CIPROTAB; CLINDAMYCIN; FLUXOR; GENTAMICIN; HEFOGENTA; METICILLIN; OFLOXACIN; PEFLOTAB; PEFLOXACIN; SPARBACT; SPARFLOXACIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DIFFUSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NIGERIA; NORMAL HUMAN; PENICILLIN RESISTANCE; PREVALENCE; URINALYSIS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 27744448614     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM (2003). Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh Indan. J. Med. Microbiol. 21: 49-51.
2. Ayliffe GAJ (1997). The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 24: suppl. 1: S74-79.
3. British Society Of Antimicrobial Chemotheraphy (2002).Disc diffusion method for antimicrobial susceptibility testing. Br. Soc. Antimicrob. Chemother. 2: 1-46.
4. Chamber HF (1979). Methicillin resistance in Staphylococci: molecular and biochemical basis and clinical implication. Clin. Microbiol. Rev. 10: 781-791.
5. Chambers HF (2001) The changing epidemiology Staphylococcus aureus? Emerg. Infect. Dis. 7:178-182.
6. Cheesbrough M (2002). District laboratory practice in tropical countries. Part II; Cambridge University Press UK. pp. 136-142.
7. Daghistani HI, Issa AA, Shehabi AA (2000). Frequency of nasal and wound isolates of Staphylococcus aureus associated with TSST-1production on Jordanian population. FEMS Immunol. Med. Microbiol. 27: 95-98.
8. Ehinmidu JO (2003). Antibiotics susceptibility patterns of urine bacterial isolates in Zaria, Nigeria. Trop. J. Pharm. Res. 2: 223-228.
9. Fluka. Zone interpretative chart using Mueller Hinton agar in accordance with WHO requirements flukatec@eurnotes.sial.com.
10. Fridkin SK (2001). Vancomycin-intermediate and resistant Staphylococcus aureus: what the infectious disease specialist need to know. Clin. Infect. Dis. 32: 108-115.
11. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM (2005). Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352: 1436-1444.
12. Gross-Schulman S, Dassey D, Mascola L, Anaya C (1998). Community-acquired methicillin-resistant Staphylococcus aureus JAMA 280: 421-422.
13. Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau YR (1999). Surveillance of antibiotic resistance in Taiwan, 1998. J. Microbiol. Immunol. Infect. 32: 239-249.
14. Kluytmans J, van Belkum, verbrugh H (1997). Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10: 505-520.
15. Lamikanra A, Ako-Nai AK, Ogunniyi DA (1996). Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigeria school children. Int. J. Antimicrob. Agents 7: 59-64.
16. Layton MC, Hierholzer WJ, Patterson JE (1995). The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect. Control Hosp. Epidemiol. 16:12-17.
17. Lelievre H, Lina G, Jones ME, Olive C, Forey F, Roussel-Delvallez M, Nicholas-Chanoine M, Bebear CM, Jarlier V, Andremont A, Vandenesch F, Etienne J (1999). Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. Journal Clin. Microbiol. 37: 3452-3457.
18. Lowy FD (1998). Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
19. Lu P, Chin L, Peng C, Chiang Y, Chin T, Ma L, Sin LK (2005). Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J. Clin. Microbiol. 43:132-139.
20. National Committee for Clinical Laboratory Standards (2002): Performance standards for antimicrobial disc susceptibility tests. Twelfth International Supplement; M100-S12.
21. Nordmann P, Naas T (2005). Transmission of methicillin-resistant Staphylococcus aureus to a microbiologist. N. Engl. J. Med. 352:1489-1490.
22. Olayinka BO, Olayinka AT, Onaolapo JA, Olurinola PF (2005).P attern of resistance to vancomycin and other antimicrobial agents in staphylococcal isolates in a university teaching hospital. Afr. Clin. Exper. Microbiol. 6: 46-52.
23. Polyzou A, Slavakis A, Pournaras S, et al. (2001): Predominance of a methicillin- resistant Staphylococcus aureus clone susceptible to erythromycin and several other non - β-lactam antibiotics in a Greek hospital. J. Antimicrob. Chemother. 48: 231-234.
24. Pournaras S, Slavakis A, Polyzou A, Maniatis AN, Sofianou D, Tsakris A (2001). Nosocomial spread of an unusual methicillin-resistance Staphylococcus aureus clone that is sensitive to non-β-lactam antibiotics, including tobramycin. J. Clin. Microbiol. 39: 779-781.
25. Simor AE (2001). Containing methicillin-resistant Staphylococcus aureus: surveillance, control and treatment methods. Postgraduate Med.110 (4):1-12
26. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003). Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9: 978-984.
27. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001). Nasal carriage as a source of Staphylococcus aureus bacteremia N. Engl. J. Med. 344: 11-16.
28. Warner JE, Onderdonk AB (2004). Diversity of toxic shock syndrome Toxin 1-positive Staphylococcus aureus isolates. Appl. Environ. Microbiol. 70: 6931-6935.
29. Weems JJ (2001). The many faces of Staphylococcus aureus infections. Postgraduate Med. 110(4): 24-36.